The Latest Cardiac and Vascular News
First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease Follows Breakthrough Device designation for Virtue Sirolimus-Eluting Balloon in coronary in-stent restenosis granted in Q2 2019 NEW HOPE, Pa., Sept. 17, 2019 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation […]
Non-invasive monitoring technology assists in managing heart failure patients TENAFLY, N.J., Sept. 14, 2019 /PRNewswire/ — Sensible Medical Innovations today announced the launch of the ReDSTM PRO system. The debut of the new system was at the Heart Failure society of America conference in Philadelphia, PA. ReDSTM PRO is optimized for the Point-of-Care, designed for use in […]
ARTIS icono biplane system enables wide variety of neuroradiology and abdominal imaging procedures ARTIS icono floor single-plane system permits vascular, interventional cardiology, surgical, and oncology procedures Product family designed to improve lab utilization and interdisciplinary usage MALVERN, Pa.–(BUSINESS WIRE)–The U.S. Food and Drug Administration (FDA) has cleared the ARTIS […]
Dr. Geall Joins the Company’s World-class Scientific Advisors in Cardiology, Vaccine Development and Human Genetics CAMBRIDGE, Mass.–(BUSINESS WIRE)–Verve Therapeutics, a next-generation cardiovascular company developing therapies that safely edit the adult human genome to permanently reduce a person’s risk of coronary artery disease, today announced the appointment of Andrew Geall, […]
– APOLLO-B Will Enroll Patients with Both Hereditary and Wild-Type Amyloidosis – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the Company has initiated APOLLO-B, a global Phase 3 placebo-controlled clinical trial of patisiran, an intravenously administered RNAi therapeutic, for the treatment of transthyretin […]
Top-line results projected to be available on or about September 30, 2019 Number of MACE increases from 250 to greater than 275 CALGARY, Alberta, Sept. 16, 2019 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) announced today that, following the completion of final patient safety visits (as reported […]
SAN CARLOS, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) — BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for the Phase III pivotal CardiAMP Heart Failure Trial, which included safety […]
Norman Radow, Managing Partner at Strul Medical Group, Joins Company’s Board NASDAQ, TSX: NVCN VANCOUVER, Sept. 16, 2019 /PRNewswire/ – Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the […]
CASTLE PINES, Colo., Sept. 16, 2019 /PRNewswire/ — Proximo Medical, LLC today announced that it is the commercial partner for BIOTRONIK, Inc.’s peripheral vascular intervention (PVI) platform in select United States markets. BIOTRONIK, a global medical technology company headquartered in Berlin, Germany with U.S. offices in New York City and Lake Oswego, Oregon, develops trusted and innovative cardiovascular and endovascular solutions. Proximo Medical is […]
SAN RAMON, Calif., Sept. 16, 2019 /PRNewswire/ — BioVentrix, Inc., a pioneer of technologies and procedures for the less invasive treatment of heart failure (HF), announced today that Pedro Marques has been named Vice President of Sales for the European market. The addition of Mr. Marques to a key leadership position marks another milestone in […]
